SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Application
Serum amyloid A (SAA) proteins comprise a family of apolipoproteins coded for by at least three genes with allelic variation and a high degree of homology between species. The synthesis of certain members of the SAA family is greatly increased during inflammation. However, SAA is not often used as an acute-phase marker, despite being at least as sensitive as C-reactive protein (CRP) in this regard.
SAA proteins can be considered as apolipoproteins since they associate primarily with plasma lipoproteins within the high-density lipoprotein (HDL) range, perhaps through their amphipathic α-helical structure. This association with HDL particles may play a role in the transport and metabolism of SAA during the acute-phase response.
Product Specification
|
Sample Volume |
WB: 20μL; Serum/Plasma: 10μL |
|
Test Time |
5 mins |
|
Measuring Range |
3-200 mg/L |
|
Pack |
20T、40T、100T |
|
Storage |
2~30℃ |
Features
Smart - Photosensitive and Luminescent Microspheres
Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed
Convenient - Room Temperature Storage & Minimal sample consumption
Clinical significance
Inflammatory Disorders
Monitoring Disease Activity in Rheumatoid Arthritis
Autoimmune Diseases
Monitoring Response to Treatment
Assessment of Infectious Diseases
Previous :
IL-6 Rapid Quantitative Test (Chemiluminescence Immunoassay)Next :
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)Please provide us with the information below, and we'll contact you as soon as possible.
Copyright © 2013-2024 Xiamen Biotime Biotechnology Co., Ltd.. All Rights Reserved.
IPv6 network supported
